Clues To Possible Drug Targets For Lou Gehrig's Disease Offered By Yeast Model

Amyotrophic lateral sclerosis, also called Lou Gehrig's disease, is a devastatingly cruel neurodegenerative disorder that robs sufferers of the ability to move, speak and, finally, breathe. Now researchers at the Stanford University School of Medicine and San Francisco's Gladstone Institutes have used baker's yeast - a tiny, one-celled organism - to identify a chink in the armor of the currently incurable disease that may eventually lead to new therapies for human patients... via Health News from Medical News Today Read More Here..